$5.16 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 95 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITCI | INTRA-CELLULAR THERAPIES INC | $65,527,000 | +40.4% | 1,251,946 | 0.0% | 1.27% | +61.5% | |
| KZR | KEZAR LIFE SCIENCES INC | $23,574,000 | +93.5% | 1,409,956 | 0.0% | 0.46% | +122.4% | |
| IFRX | INFLARX NV | $15,637,000 | +83.8% | 3,285,000 | 0.0% | 0.30% | +111.9% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $14,627,000 | -33.9% | 9,142,067 | 0.0% | 0.28% | -24.1% | |
| DICE THERAPEUTICS INC | $10,377,000 | -22.7% | 410,000 | 0.0% | 0.20% | -11.1% | ||
| MOLN | MOLECULAR PARTNERS AGads | $7,672,000 | -2.2% | 400,000 | 0.0% | 0.15% | +12.9% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $5,576,000 | +14.7% | 851,291 | 0.0% | 0.11% | +31.7% | |
| RACB | RESEARCH ALLIANCE CORP II | $4,885,000 | -0.8% | 500,000 | 0.0% | 0.10% | +14.5% | |
| NUVALENT INC | $3,808,000 | -15.6% | 200,000 | 0.0% | 0.07% | -2.6% | ||
| IMMUNEERING CORP | $3,234,000 | -39.1% | 200,000 | 0.0% | 0.06% | -29.2% | ||
| OMEG | OMEGA ALPHA SPACcl a | $2,931,000 | +0.3% | 300,000 | 0.0% | 0.06% | +16.3% | |
| EBAC | EUROPEAN BIOTECH ACQUTN CORP | $2,907,000 | +0.2% | 300,000 | 0.0% | 0.06% | +14.3% | |
| BNTC | BENITEC BIOPHARMA INC | $2,015,000 | -26.6% | 769,000 | 0.0% | 0.04% | -15.2% | |
| BLSA | BCLS ACQUISITION CORP | $1,960,000 | -1.6% | 200,000 | 0.0% | 0.04% | +11.8% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $1,964,000 | +0.3% | 200,000 | 0.0% | 0.04% | +15.2% | |
| CANOWS | CANO HEALTH INC*w exp 06/03/202 | $1,612,000 | -42.1% | 674,566 | 0.0% | 0.03% | -34.0% | |
| DBTX | DECIBEL THERAPEUTICS INC | $1,226,000 | -39.7% | 263,600 | 0.0% | 0.02% | -29.4% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $976,000 | -0.2% | 99,999 | 0.0% | 0.02% | +18.8% | |
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $853,000 | -0.7% | 87,498 | 0.0% | 0.02% | +21.4% | |
| FSRXW | FINSERV ACQUISITION CORP II*w exp 02/17/202 | $169,000 | -30.5% | 273,149 | 0.0% | 0.00% | -25.0% | |
| EBACW | EUROPEAN BIOTECH ACQUTN CORP*w exp 03/06/202 | $60,000 | -3.2% | 100,000 | 0.0% | 0.00% | 0.0% | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $45,000 | -2.2% | 66,666 | 0.0% | 0.00% | 0.0% | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $19,000 | -20.8% | 33,333 | 0.0% | 0.00% | – | |
| FLACW | FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202 | $17,000 | -15.0% | 29,166 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.